v3.26.1
Statements of Cash Flows - CAD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Operating activities      
Net loss for the year $ (929,987) $ (3,912,888) $ (43,450)
Adjustments for:      
Amortization of right-of-use asset 20,177 20,175 20,175
Equity-settled share-based compensation 273,147 350,834 425,460
Flow through premium recovery 0 (769,231) 0
Office lease accretion per IFRS 16 1,748 4,722 7,360
Office base rent recorded as lease reduction per IFRS 16 (28,165) (28,164) (28,056)
Property acquisition and assessments costs 690,000 7,500 7,500
Interest expense - director's loans 100,000 99,000 101,274
Transaction cost - director's loan 34,678 181,357 136,942
Changes in working capital items      
Amounts receivable and other assets (344) 106,149 2,227
Restricted cash 282 20,000 5,006
Accounts payable and accrued liabilities 113,429 (347,886) (52,056)
Advanced contributions received (105,947) (4,497,191) 1,008,372
Balance due to related parties 33,667 130,905 (383,179)
Net cash provided by (used in) operating activities 202,685 (8,634,718) 1,207,575
Financing activities      
Net proceeds from issuance of common shares pursuant to a private placement 0 0 2,769,231
Repayment of director's loans interest (50,136) (99,000) (101,274)
Proceeds from exercise of share purchase warrants 0 350,000 0
Proceeds from option exercise 50,167 587,973 0
Net cash provided by financing activities 31 838,973 2,667,957
Net increase (decrease) in cash 202,716 (7,795,745) 3,875,532
Cash, beginning balance 1,211,297 9,007,042 5,131,510
Cash, ending balance $ 1,414,013 $ 1,211,297 $ 9,007,042